Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]

View source ↗

Summary

A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Choroid Plexus Tumor
• Ependymoma
• Glioblastoma
• Medulloblastoma
• Meningioma
• Oligodendroglioma
• Vestibular Schwannoma

Drugs mentioned

• 68Ga-DOTATOC (DOTATOC)

Snippet

Sponsor: Sue O'Dorisio | Conditions: Acoustic Schwannoma, Adult Anaplastic Astrocytoma | NA | Status: WITHDRAWN